An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex.
about
JAK2 tyrosine kinase phosphorylates PAK1 and regulates PAK1 activity and functionsGas6-Axl pathway: the role of redox-dependent association of Axl with nonmuscle myosin IIBCdc42/Rac1-mediated activation primes PAK2 for superactivation by tyrosine phosphorylation.Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis.Dedicated myosin light chain kinases with diverse cellular functions.Emerging functions of p21-activated kinases in human cancer cells.PAK1 as a therapeutic target.Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread-Identification of a Promising Novel therapeutic target.Synergistic Activation of ERα by Estrogen and Prolactin in Breast Cancer Cells Requires Tyrosyl Phosphorylation of PAK1.EGFR family: structure physiology signalling and therapeutic targets.Diversification of caldesmon-linked actin cytoskeleton in cell motility.Dynein light chain 1 phosphorylation controls macropinocytosis.Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-alpha signaling complex.Renal cell cultures for the study of growth factor interactions underlying kidney organogenesis.Activation of Rho is required for ligand-independent oncogenic signaling by a mutant epidermal growth factor receptor.p21-activated protein kinase 4 (PAK4) interacts with the keratinocyte growth factor receptor and participates in keratinocyte growth factor-mediated inhibition of oxidant-induced cell death.Grb2 signaling in cell motility and cancer
P2860
Q28242536-DB4AE4BB-3FAA-4AA8-90E9-78207A440221Q28564875-2198A42F-A562-4714-9462-295CF7A10D5BQ28646420-EE0574CF-2313-41C8-92F9-14DDEA73F340Q30164460-DE2D5737-81A9-4AD6-BCA5-E178EBDDD748Q34092402-B9D24719-03F7-4726-AE79-D1A9A5805C17Q34972819-A0743198-CCDB-4931-90C3-8BB8CACD7FBCQ35108164-18A95A59-70D9-4BCC-8EF8-DD3EAB645C31Q36037996-D18107F9-D066-4495-A1F2-7F1C495953DAQ36918232-BFBF99B5-6317-4548-84A7-98045D031C50Q37272623-EEFBD949-619F-45F0-AE12-152671C2A978Q37847039-60C6A6D9-1987-4494-BA3F-43A998F6A086Q40500063-8751C28C-5C55-461A-97BF-6C5726D27B98Q40642077-BCDF3DE5-A5E1-40B9-9139-A3CADD2490BDQ40798044-F989F685-AA74-48CF-9EC6-71F19F420A28Q43511394-F0502988-BA00-46D2-A02B-5E72BAF3171BQ44279240-789718D9-B85E-4C9A-9FA7-C410BBB80E23Q58199697-3E8F008E-533A-48F4-BAE4-4A35AEA36D8A
P2860
An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
An oncogenic epidermal growth ...... yosin phosphotyrosine complex.
@en
type
label
An oncogenic epidermal growth ...... yosin phosphotyrosine complex.
@en
prefLabel
An oncogenic epidermal growth ...... yosin phosphotyrosine complex.
@en
P2093
P2860
P356
P1476
An oncogenic epidermal growth ...... yosin phosphotyrosine complex.
@en
P2093
A J Danielsen
J L Boerner
M J McManus
N J Maihle
P2860
P304
35328-35334
P356
10.1074/JBC.M005399200
P407
P577
2000-11-01T00:00:00Z